Yoga as an Adjunct Intervention for Chemotherapy-Induced Peripheral Neuropathy: Evidence, Challenges, and Future...

Area of Science:

• Oncology
• Neurology
• Integrative Medicine

Background:

• Chemotherapy-induced peripheral neuropathy (CIPN) significantly impacts cancer patient quality of life (QOL) through sensory and emotional distress.
• Current interventions for CIPN are often insufficient, highlighting the need for novel adjunctive therapies.
• Yoga, incorporating mindful movement, breathwork, and meditation, presents a holistic approach to address CIPN's physical and psychosocial effects.

Discussion:

• Preliminary studies indicate yoga's potential to alleviate pain, improve function, and enhance psychological well-being in CIPN patients.
• Limitations in existing research include small sample sizes and methodological inconsistencies.
• Barriers to yoga adoption in CIPN management include clinician skepticism, accessibility issues, and diverse research protocols.

Key Insights:

• Yoga shows promise as an adjunct therapy for chemotherapy-induced peripheral neuropathy.
• Mindful movement, breathwork, and meditation are core components of yoga's therapeutic potential.
• Addressing research and implementation barriers is crucial for wider adoption.

Outlook:

• Future research should prioritize large-scale, standardized clinical trials to establish yoga's efficacy in CIPN.
• Qualitative studies exploring patient experiences with yoga are essential for patient-centered care.
• Telehealth delivery models and multidisciplinary care integration can enhance yoga's accessibility and impact in oncology.
• Standardized yoga interventions and telehealth delivery can improve accessibility and strengthen the evidence base for yoga in managing CIPN.